AU1044783A - Monoclonal antibodies against leishmania - Google Patents

Monoclonal antibodies against leishmania

Info

Publication number
AU1044783A
AU1044783A AU10447/83A AU1044783A AU1044783A AU 1044783 A AU1044783 A AU 1044783A AU 10447/83 A AU10447/83 A AU 10447/83A AU 1044783 A AU1044783 A AU 1044783A AU 1044783 A AU1044783 A AU 1044783A
Authority
AU
Australia
Prior art keywords
monoclonal antibodies
antibodies against
against leishmania
leishmania
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10447/83A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU1044783A publication Critical patent/AU1044783A/en
Abandoned legal-status Critical Current

Links

AU10447/83A 1981-11-17 1982-11-17 Monoclonal antibodies against leishmania Abandoned AU1044783A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US322241 1994-10-12

Publications (1)

Publication Number Publication Date
AU1044783A true AU1044783A (en) 1983-06-01

Family

ID=

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610946B2 (en) * 1987-11-05 1991-05-30 Hybritech Incorporated Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU610946B2 (en) * 1987-11-05 1991-05-30 Hybritech Incorporated Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics

Similar Documents

Publication Publication Date Title
AU1157183A (en) Bispecific antibody determinants
JPS57196154A (en) Monochronal antibody
GB8426467D0 (en) Monoclonal antibodies
GB8422650D0 (en) Monoclonal antibodies
GB8426463D0 (en) Monoclonal antibodies
GB8422653D0 (en) Monoclonal antibodies
AU569816B2 (en) Monoclonal anti-alpha-amylase antibody
PT79896A (en) Monoclonal antibody
AU8594382A (en) Immunoassay using biotin-avidin-enzyme complex
IL67295A0 (en) Monoclonal antibodies against leishmania
GB8504271D0 (en) Monoclonal antibody
GB8426461D0 (en) Monoclonal antibodies
GB8426464D0 (en) Monoclonal antibodies
GB8422651D0 (en) Monoclonal antibodies
GB8426468D0 (en) Monoclonal antibodies
GB8422649D0 (en) Monoclonal antibodies
GB8431171D0 (en) Monoclonal antibodies
GB8426459D0 (en) Monoclonal antibodies
GB8426470D0 (en) Monoclonal antibodies
AU618720B2 (en) Monoclonal antibodies
GB8416845D0 (en) Monoclonal antibodies
GB8426469D0 (en) Monoclonal antibodies
GB8419456D0 (en) Monoclonal antibodies
GB8426465D0 (en) Monoclonal antibodies
AU1044783A (en) Monoclonal antibodies against leishmania